Suppr超能文献

阿芬太尼诱发的癫痫样活动:复杂部分性癫痫的同步头皮和深部脑电图研究

Alfentanil-induced epileptiform activity: a simultaneous surface and depth electroencephalographic study in complex partial epilepsy.

作者信息

Ross J, Kearse L A, Barlow M K, Houghton K J, Cosgrove G R

机构信息

Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, U.S.A.

出版信息

Epilepsia. 2001 Feb;42(2):220-5. doi: 10.1046/j.1528-1157.2001.18600.x.

Abstract

PURPOSE

Alfentanil is a high potency mu opiate receptor agonist commonly used during presurgical induction of anesthesia. This and other opiate receptor agonists have demonstrated proconvulsant effects in animals, but these properties have been less consistently demonstrated in humans. Most human scalp EEG studies have failed to demonstrate induction of epileptiform activity with these agents, which is inconsistent with findings using intracranial EEG. Simultaneous scalp and depth EEG recordings have yet to be performed in this setting. The relationship between opiate dose and proconvulsant activity is unclear.

METHODS

Simultaneous scalp and depth electrode recordings were performed on five patients with complex partial epilepsy (CPE) who underwent alfentanil anesthesia induction before depth electrode removal. Consecutive equal bolus doses of alfentanil were administered to each patient according to strict time intervals so as to assess their correlation with any induced epileptiform activity.

RESULTS

Epileptiform activity was induced by alfentanil in three of five patients. Two of these patients had electrographic seizures. Epileptiform activity was only detected from the depth electrodes, occurring within 2 min of the first bolus dose in all three cases. Further increase or spread of epileptiform activity did not occur despite cumulative bolus doses of alfentanil.

CONCLUSIONS

Alfentanil is proconvulsant in patients with CPE. Induced seizures may be subclinical and lack a scalp EEG correlate. There is a complex dose-response relationship. Alfentanil induction of anesthesia should be approached with caution in patients with CPE.

摘要

目的

阿芬太尼是一种高效μ阿片受体激动剂,常用于术前麻醉诱导。这种及其他阿片受体激动剂在动物实验中已显示出惊厥前效应,但在人类中这些特性的表现并不一致。大多数人类头皮脑电图研究未能证明使用这些药物会诱发癫痫样活动,这与颅内脑电图的研究结果不一致。在这种情况下,尚未进行头皮和深部脑电图同步记录。阿片剂量与惊厥前活动之间的关系尚不清楚。

方法

对5例复杂性局灶性癫痫(CPE)患者在拔除深部电极前进行阿芬太尼麻醉诱导时,同时进行头皮和深部电极记录。按照严格的时间间隔给每位患者连续给予等量的阿芬太尼推注剂量,以评估其与任何诱发的癫痫样活动的相关性。

结果

5例患者中有3例在使用阿芬太尼后诱发了癫痫样活动。其中2例患者出现了脑电图癫痫发作。癫痫样活动仅在深部电极检测到,所有3例均在首次推注剂量后2分钟内出现。尽管累积给予阿芬太尼推注剂量,但癫痫样活动未进一步增加或扩散。

结论

阿芬太尼在CPE患者中具有惊厥前作用。诱发的癫痫发作可能是亚临床的,且缺乏头皮脑电图相关性。存在复杂的剂量反应关系。对于CPE患者,应谨慎使用阿芬太尼进行麻醉诱导。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验